| Metric | შპს ნიუ ფარმა NEW PHARMA | შპს ორი ნაბიჯი |
|---|---|---|
| Growth | ||
| Revenue | ₾883₾4.1m | ₾1.12bn₾878.7m |
| Revenue growth | -100.0% | 27.1% |
| Profitability | ||
| EBITDA | -₾262k-₾476k | ₾109.0m₾86.9m |
| EBITDA margin | -29687.2%-11.6% | 9.8%9.9% |
| Net profit | -₾258k-₾726k | ₾57.2m₾54.0m |
| Net margin | -29249.2%-17.7% | 5.1%6.1% |
| Balance sheet | ||
| Total assets | ₾83k₾1.4m | ₾296.9m₾284.6m |
| Total equity | -₾780k-₾522k | ₾2.3m₾2.5m |
| ROE | — | 2458.9%2184.6% |